Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001649553-25-000035·ATOSSA THERAPEUTICS, INC.
Schedule 13G ownership disclosure
Atossa Therapeutics Inc
Common Stock, $0.18 par value per share · CUSIP: 04962H506
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CVI Investments, Inc.
Shares: 5,662,500 · Class: 4.3%
- Heights Capital Management, Inc.
Shares: 5,662,500 · Class: 4.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001649553-25-000035
- Form type
- SCHEDULE 13G/A
- Filer
- ATOSSA THERAPEUTICS, INC.
- CIK
- CIK 1488039
- Filed
- Feb 07, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership